Piedmont Hematology Oncology Kernersville, NC - 27284

Piedmont Hematology Oncology is categorized under Oncologists in Kernersville, NC and active since 2008.

Piedmont Hematology Oncology was established in 2008, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 6214930 by the NAICS.

If you are seeking more information, feel free to contact Treasa Creson, Manager at the company’s single location by writing to 445 Pineview Drive # 200, Kernersville, North Carolina NC 27284 or by phoning (336) 993-6663. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Piedmont Hematology Oncology
Contact Person: Treasa Creson, Manager
Address: 445 Pineview Drive # 200, Kernersville, North Carolina 27284
Phone Number: (336) 993-6663
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Oncologists
SIC Code: 8011
NAICS Code: 6214930
Share This Business:

Piedmont Hematology Oncology was started in 2008 to provide professional Oncologists under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Treasa Creson, Manager for inquiries that concern Piedmont Hematology Oncology by calling the company number (336) 993-6663, as your correspondence is most welcome. Additionally, the physical location of the single location of Piedmont Hematology Oncology can be found at the coordinates 36.11324,-80.06948 as well as the street address 445 Pineview Drive # 200 in Kernersville, North Carolina 27284.

For its online presence, you may visit Piedmont Hematology Oncology’s website at and engage with its social media outlets through on Twitter and on Facebook.